These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16493256)

  • 1. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients.
    Kayl AE; Meyers CA
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing patient perceptions of the side effects of cancer chemotherapy.
    Carelle N; Piotto E; Bellanger A; Germanaud J; Thuillier A; Khayat D
    Cancer; 2002 Jul; 95(1):155-63. PubMed ID: 12115329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs.
    Elkin EB; Weinstein MC; Kuntz KM; Bunnell CA; Weeks JC
    Breast Cancer Res Treat; 2005 Sep; 93(1):25-34. PubMed ID: 16184455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
    Knobf MT
    Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life for patients with epithelial ovarian cancer.
    Sun CC; Ramirez PT; Bodurka DC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):18-29. PubMed ID: 17183353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patients' experience of breast cancer treatment].
    Grønvold M; Jensen AB
    Ugeskr Laeger; 2007 Sep; 169(37):3114-7. PubMed ID: 17877963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
    Browall M; Ahlberg K; Karlsson P; Danielson E; Persson LO; Gaston-Johansson F
    Eur J Oncol Nurs; 2008 Jul; 12(3):180-9. PubMed ID: 18343197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
    Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC; Wang W; Hartzema AG; Wagner S
    Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sexual functioning and information needs in women with premature menopause following breast cancer treatment].
    Mannor B; Zohar H
    Harefuah; 2006 Feb; 145(2):90-4, 168. PubMed ID: 16509409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life issues in the management of ovarian cancer.
    Fish LS; Lewis BE
    Semin Oncol; 1999 Feb; 26(1 Suppl 1):32-9. PubMed ID: 10071971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life as a treatment endpoint in metastatic breast cancer.
    Osoba D
    Can J Oncol; 1995 Dec; 5 Suppl 1():47-53. PubMed ID: 8853525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.
    Courneya KS; Segal RJ; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; McKenzie DC
    J Clin Oncol; 2007 Oct; 25(28):4396-404. PubMed ID: 17785708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
    Genre D; Protière C; Macquart-Moulin G; Gravis G; Camerlo J; Alzieu C; Maraninchi D; Moatti JP; Viens P
    Support Care Cancer; 2002 Apr; 10(3):222-30. PubMed ID: 11904787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence.
    Ding Y; Zhu YL; Zhang MF
    Cancer Nurs; 2007; 30(3):243-51. PubMed ID: 17510589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer.
    Williams SA; Schreier AM
    Oncol Nurs Forum; 2004; 31(1):E16-23. PubMed ID: 14722602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.